SYK
STRYKER CORP
Healthcare • CIK 0000310764
Loading...
Market Cap
$125.98B
P/E (TTM)
37.7x
Rev Growth (TTM)
+8.8%
Net Margin (TTM)
13.2%
FCF Yield (TTM)
3.6%
FCF Margin (TTM)
18.1%
Filings
Primary-source SEC disclosures, read end-to-end — every figure traceable to its filing.
10-QJul 20262026-07-31source
8-KEarnings2026-07-30source
8-KJun 20262026-06-26source
8-KMay 20262026-05-20source
10-Q2026 Q12026-05-11source
What your agent reads
Company-published material — management’s own words, not SEC-audited. Each source below is labeled so your agent knows what to verify.
Company-published, not SEC-audited
Earnings
Q2 2026
18 days ago
8-K releaseRevenue
$6.59B
+9.4%
Net Income
$1.28B
+44.3%
EPS
N/A
—
Most recent quarterly earnings snapshot
Cash Flow Health
Free Cash Flow8/8 positive
TTM$4.6B
Q1 '26
$415M-78%
Q4 '25
$1.9B+39%
FCF Margin
TTM18.1%
Q1 '266.9%-74%
Sector: 0.0%Top 10%
OCF Margin21.3%
OCF/NI1.61x
CapEx Coverage6.7x
FCF Yield3.6%
FCF Growth (2Y)+26%
Cash Conversion Cycle
267 days
DSO: 55+DIO: 212−DPO: –
Cash flow trends & capital efficiency
Capital Allocation
Total Shareholder Yield
TTM1.0%
Div Yield1.0%
+Buybacknot disclosed
Dividend & Payout Metrics
Dividend Yield (TTM)1.0%
FCF Payout Ratio28.5%
Free Cash Flow (TTM)$4.6B
Capital Return / FCF28.5%
Est. Dividends Paid (TTM)$1.3B
Buyback data not disclosed in this company's filings.
Shows how management rewards shareholders
Valuation Metrics
Price-to-EarningsTTM
37.7x
Volatile
8Q: 41.8x-538%
Valuation Lenses
Earnings
37.7x
vs – sector
Cash Flow
33.6x
EV/FCF vs –
Growth-Adj
2.2xPEG
Expensive for growth
Quality-Adj
4.0P/E per %ROIC
ROIC: 9.5%
Shareholder Returns
Dividend
1.0%
Buyback
–
Total Yield
1.0%
Market Cap$125.98B
EV$137.74B
Multi-angle valuation analysis with sector context
Margins & Efficiency
ROIC 75th pctile
Profitability Cascade
Gross
63.8%
Operating
19.7%
Top 25% in sector
Net
13.2%
Margins Unknown
Return on Invested CapitalTTM
9.5%
Stable
+0.0% YoY-0.3%
P25MedianP75
75th pctl (med: -0.0%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
14.3%
8Q: 15.7%
Asset Turnover
0.54x
8Q: 0.53x
Leverage (1+D/E)
1.64x
D/E: 0.64x
DuPont: 12.7% ≈ 9.5% ROIC
Asset & CapEx Efficiency
Fixed Asset Turn
6.73x
8Q:6.63x
-4.9%
Invested Cap Turn
0.71x
8Q:0.72x
-6.0%
CapEx Intensity
2.3%
8Q:2.1%
CapEx/Depreciation
0.50x
FCF vs Net Margin Gap+4.9 pts
Margin trends, ROIC, and capital efficiency
Balance Sheet & Solvency
D/E 0.64x
Net Debt / EBITDA
–Net Debt: $11.76B
Interest Coverage
–
Leverage Metrics
Debt-to-Equity
0.64x
Balance sheet risk & solvency analysis
Related Research
3 related posts